Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease

Affiliations

¹ Departments of Epidemiology and Cardiology, Erasmus MC-University Medical Center Rotterdam, The Netherlands. Department of Clinical Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.

Editorial

Maarten J G Leening. Circulation. 2020 Sep.

. 2020 Sep;142(9):838-840.

doi: 10.1161/CIRCULATIONAHA.120.048340. Epub 2020 Aug 31.

¹ Departments of Epidemiology and Cardiology, Erasmus MC-University Medical Center Rotterdam, The Netherlands. Department of Clinical Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.

No abstract available

Keywords: Editorials; cardiovascular diseases; hydroxymethylglutaryl-CoA reductase inhibitors; prevention & control.

Comment on

The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering.
Pencina MJ, Pencina KM, Lloyd-Jones D, Catapano AL, Thanassoulis G, Sniderman AD. Pencina MJ, et al. Circulation. 2020 Sep;142(9):827-837. doi: 10.1161/CIRCULATIONAHA.120.045851. Epub 2020 Jul 23. Circulation. 2020. PMID: 32700572